Anning Zuo

机构：First Affiliated Hospital of Zhengzhou University · ORCID：0009-0006-6779-8282

发表论文 33 篇 · 总被引 717 次 · h-index 13

代表论文

• Multi-stage mechanisms of tumor metastasis and therapeutic strategies (2024 · Signal Transduction and Targeted Therapy · 被引 169)
• THBS2 + cancer-associated fibroblasts promote EMT leading to oxaliplatin resistance via COL8A1-mediated PI3K/AKT activation in colorectal cancer (2024 · Molecular Cancer · 被引 88)
• Metabolic checkpoints in immune cell reprogramming: rewiring immunometabolism for cancer therapy (2025 · Molecular Cancer · 被引 55)
• Copper in cancer: friend or foe? Metabolism, dysregulation, and therapeutic opportunities (2025 · 癌症：英文版 · 被引 37)
• THBS2-producing matrix CAFs promote colorectal cancer progression and link to poor prognosis via the CD47-MAPK axis (2025 · Cell Reports · 被引 25)
• Circadian disruption in cancer hallmarks: Novel insight into the molecular mechanisms of tumorigenesis and cancer treatment (2024 · Cancer Letters · 被引 25)